IL142362A0 - Ureidopiperidine derivatives as selective human nk3 receptor antagonists - Google Patents

Ureidopiperidine derivatives as selective human nk3 receptor antagonists

Info

Publication number
IL142362A0
IL142362A0 IL14236299A IL14236299A IL142362A0 IL 142362 A0 IL142362 A0 IL 142362A0 IL 14236299 A IL14236299 A IL 14236299A IL 14236299 A IL14236299 A IL 14236299A IL 142362 A0 IL142362 A0 IL 142362A0
Authority
IL
Israel
Prior art keywords
ureidopiperidine
derivatives
receptor antagonists
selective human
selective
Prior art date
Application number
IL14236299A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL142362A0 publication Critical patent/IL142362A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IL14236299A 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human nk3 receptor antagonists IL142362A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812859A FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant
PCT/FR1999/002355 WO2000021931A1 (fr) 1998-10-09 1999-10-04 Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains

Publications (1)

Publication Number Publication Date
IL142362A0 true IL142362A0 (en) 2002-03-10

Family

ID=9531536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14236299A IL142362A0 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human nk3 receptor antagonists

Country Status (25)

Country Link
US (1) US6465489B1 (xx)
EP (1) EP1119552A1 (xx)
JP (1) JP2002527423A (xx)
KR (1) KR20010085903A (xx)
CN (1) CN1133622C (xx)
AR (1) AR029148A1 (xx)
AU (1) AU751592B2 (xx)
BR (1) BR9914397A (xx)
CA (1) CA2346729A1 (xx)
CO (1) CO5180555A1 (xx)
DZ (1) DZ2905A1 (xx)
EA (1) EA003613B1 (xx)
EE (1) EE200100214A (xx)
FR (1) FR2784377B3 (xx)
HU (1) HUP0201709A3 (xx)
IL (1) IL142362A0 (xx)
IS (1) IS5897A (xx)
NO (1) NO20011779L (xx)
NZ (1) NZ510779A (xx)
PL (1) PL347910A1 (xx)
SK (1) SK4642001A3 (xx)
TR (1) TR200101030T2 (xx)
TW (1) TW539669B (xx)
WO (1) WO2000021931A1 (xx)
YU (1) YU26001A (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476050B2 (en) 2000-03-14 2002-11-05 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
US20060128752A1 (en) * 2002-07-03 2006-06-15 Giuseppe Alvaro Chemical compounds
US20110144081A1 (en) 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US9554659B2 (en) 2012-10-22 2017-01-31 Uwm Research Foundation, Inc. Infant sleep pod
WO2020101017A1 (ja) * 2018-11-15 2020-05-22 国立大学法人九州大学 Il-31介在性疾患の予防又は治療剤及び医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) * 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
TR200101030T2 (tr) 2001-08-21
US6465489B1 (en) 2002-10-15
CN1329594A (zh) 2002-01-02
EP1119552A1 (fr) 2001-08-01
EA003613B1 (ru) 2003-06-26
KR20010085903A (ko) 2001-09-07
NO20011779L (no) 2001-06-07
AU751592B2 (en) 2002-08-22
WO2000021931A1 (fr) 2000-04-20
IS5897A (is) 2001-03-16
HUP0201709A3 (en) 2003-03-28
AU5988799A (en) 2000-05-01
PL347910A1 (en) 2002-04-22
SK4642001A3 (en) 2001-09-11
CA2346729A1 (en) 2000-04-20
DZ2905A1 (fr) 2004-03-01
BR9914397A (pt) 2001-06-26
CN1133622C (zh) 2004-01-07
YU26001A (sh) 2003-04-30
HUP0201709A2 (en) 2002-09-28
EE200100214A (et) 2002-08-15
CO5180555A1 (es) 2002-07-30
TW539669B (en) 2003-07-01
AR029148A1 (es) 2003-06-18
FR2784377B3 (fr) 2000-11-17
FR2784377A1 (fr) 2000-04-14
NZ510779A (en) 2003-07-25
NO20011779D0 (no) 2001-04-06
JP2002527423A (ja) 2002-08-27
EA200100299A1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
PL348375A1 (en) Pyrrolidine derivatives-ccr-3 receptor antagonists
HK1019149A1 (en) Indole derivatives useful as endothelin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
IL150033A0 (en) Selective neurokinin antagonists
GB2343891B (en) 4-Aroyl-piperidine CCR-3 receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
SG80041A1 (en) Muscarinic receptor antagonists
IL142045A0 (en) Naphthalenecarboxamides as tachykinin receptor antagonists
EP0929218A4 (en) R2Y RECEPTOR ANTAGONISTS
IL146151A0 (en) Human-g-protein receptor
HUP9903480A3 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
IL142362A0 (en) Ureidopiperidine derivatives as selective human nk3 receptor antagonists
HUP9903439A2 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
GB9820014D0 (en) Receptor antagonists and uses thereof
EP1039903A4 (en) INTERLEUKIN-8 RECEPTOR ANTAGONISTS
EP1047424A4 (en) IL-8 RECEPTOR ANTAGONISTS
AU2574801A (en) Selective iGLUR5 receptor antagonists
EP1131335A4 (en) 7TM RECEPTOR HLWAR77
EP1100813A4 (en) HUMAN BOMBESIN RECEPTOR 3Sb POLYPEPTIDE
EP1083909A4 (en) hCEPR RECEPTOR
IL140983A0 (en) Il-8 receptor antagonists
GB9811283D0 (en) Vironectin receptor antagonists
EP1109565A4 (en) GABAB1AA RECEPTOR
GB9814737D0 (en) Fibrinogen receptor antagonists
SI0912556T1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists